key: cord-1029445-15v3nz8h
authors: Sissa, Cinzia; Al-Khaffaf, Ahmad; Frattini, Francesco; Gaiardoni, Roberta; Mimiola, Elda; Montorsi, Paolo; Melara, Barbara; Amato, Massimo; Peyvandi, Flora; Franchini, Massimo
title: Relapse of thrombotic thrombocytopenic purpura after COVID-19 vaccine
date: 2021-04-16
journal: Transfus Apher Sci
DOI: 10.1016/j.transci.2021.103145
sha: e6bfabb0136ccfa5e21f2949766097f6deb2b22f
doc_id: 1029445
cord_uid: 15v3nz8h

nan

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

We report a case of a 48-year-old white female patient with a history of relapsing thrombotic thrombocytopenic purpura (TTP). The patient has been known to our department since 2015 when she was diagnosed for the first time with TTP with a high antibody titer (99 U/mL) against 

The authors declare no conflicts of interest.

Adjuvanted influenza-H1N1 vaccination reveals lymphoid signatures of age-dependent early responses and of clinical adverse events

Influenza-associated thrombotic microangiopathies

Vaccination and thrombotic thrombocytopenic purpura

Refractory thrombotic thrombocytopenic purpura following influenza vaccination

The authors thank Dr. Rachel Stenner for her revision of the language of this manuscript.J o u r n a l P r e -p r o o f